Research
Long-Acting PrEP Injection Windows: Missed-Dose Rules, Access Data and Country Status (2026)
Two long-acting PrEP injections, two very different late windows: cabotegravir tolerates plus or minus 7 days around the two-month date, lenacapavir plus or minus 14 days around week 26 with an oral bridge. Plus the IDWeek 2026 finding that 41% never received an injection.